Japan's Nikkei rebounds from 5-day losing streak, US economy worries weigh
TOKYO, Sept 10 (Reuters) -Japan's Nikkei share average rebounded from a five-day losing streak on Tuesday as investors scooped up stocks that had fallen too much, although uncertainties about the U.S. economic outlook capped gains.
The Nikkei .N225 was up 0.08% at 36,244.22 points by the midday break, after erasing most of its 0.9% gain earlier in the session.
The broader Topix .TOPX rose 0.34% to 2,588.52.
"Investors scooped up stocks after sell-offs in the past several days but the market could not be completely bullish as there are many uncertainties, such as the outlook of the U.S. economy," said Fumio Matsumoto, chief strategist at Okasan Securities.
"The market view on the U.S. economy, as well as the foreign currency markets, are divided," Matsumoto said.
Technology stocks led the Nikkei's gains, with chip-making equipment maker Tokyo Electron 8035.T rising 2.88% to become the biggest boost for the index.
Technology investor SoftBank Group 9984.T rose 0.95% and chip-testing equipment maker Advantest 6857.T climbed 0.39%.
"We cannot say the market has regained momentum until the Nikkei rises to around the 39,000 level," said Shigetoshi Kamada, general manager of the research department at Tachibana Securities.
Drug maker Daiichi Sankyo 4568.T tanked 8.56% after trials showed an experimental drug, which the drug maker has jointly developed with UK-based AstraZeneca AZN.L, did not significantly improve overall survival in lung cancer patients in a late-stage trial.
Joban Kosan 9675.T surged 8% to 1,663 yen after the operator of the Hawaiian-themed resort complex in Fukushima said an investment fund Fortress Investment Group would buy the firm for about 14 billion yen ($98 million) in a public tender offer at 1,650 yen.
($1 = 143.2800 yen)
Reporting by Junko Fujita; Editing by Mrigank Dhaniwala
Related Assets
Latest News
Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.
All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.
Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.
